Philadelphia, USA-based Medicus Pharma and Boston-based biotech Helix Nanotechnologies have entered into a non-binding ...

A Seoul-based biotech company, founded to develop innovative therapies for neurodegenerative and immune disorders.

Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla (donanemab-azbt) continued to demonstrate ...

A clinical‑stage biotech company developing gene therapies to treat common joint diseases such as knee osteoarthritis, which ...

Chinese biotech Mabgeek Biotechnology has filed to go public in Hong Kong, seeking to raise funds to support development of ...

Chinese biotech TenNor Therapeutics has filed to list on the main board of the Hong Kong Stock Exchange, aiming to fund ...

Allogene Therapeutics, a US biotech developing allogeneic CAR T products for cancer and autoimmune disease, closed 12% lower ...

New York-based Spine BioPharma on Friday revealed disappointing results with its growth factor beta (TGF-β) antagonist, SB-01 ...

Founded by experts in psychiatry and neuroscience to target neural circuits causally linked to disease, the company employs ...

The USA and Europe reached an agreement yesterday on import duties, but the details are still being worked out. However, the ...

Denmark’s pharmaceutical industry body has warned that a new European health data regulation could hamper medical innovation ...

The German Federal Joint Committee (G-BA) has commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to ...